Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023 2023-09-28 20:00
Mabwell Announces First Patient Dosed in Phase Ib/II Trial of its Novel Nectin-4 Targeting ADC in Combination with PD-1 Inhibitor 2023-09-28 20:00
IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023 2023-09-28 18:09
Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic Syndromes 2023-09-28 10:07
BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China 2023-09-28 09:46
Antengene To Present Results From Five Studies at 2023 SITC Annual Meeting 2023-09-28 08:30
Everest Medicines Announces Approval of XERAVA® in Taiwan for the Treatment of Complicated Intra-Abdominal Infections in Adult Patients 2023-09-28 07:38
OBiO has launched its state-of-the-art GMP production facility Intelli-M to expedite innovative and advanced therapies to patients who are in need. 2023-09-27 21:00
Besins Healthcare Unveils State-of-the-Art Hormone Factory in Muel, Spain, Amplifying Global Production Capabilities by 30% 2023-09-27 15:56
HRH Princess Astrid of Belgium visits Telix's New European Manufacturing Facility in Brussels South 2023-09-27 12:00
'Bayer For Her' Supporting 365 Days Conversations of Care to More Women in Asia 2023-09-27 10:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference 2023-09-27 08:30
ABM Therapeutics' ABM-1310 Granted Fast Track Designation by the FDA Following Orphan Drug Designation 2023-09-27 00:00
Latest Updates of Viva's Portfolio Companies 2023-09-26 21:06
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering 2023-09-26 21:00
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update 2023-09-26 20:51
YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine 2023-09-26 20:30
WuXi Vaccines Launches Its First Vaccines CDMO Site in China 2023-09-26 15:41
Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma 2023-09-26 08:10
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology 2023-09-25 19:00
1 39 40 41 42 43 374